Bavarian Nordic to Host Full Year 2010 Conference Call

8 maart 2011 KVISTGÅRD, Denmark - March 8, 2011 - Bavarian Nordic A/S (NASDAQ OMX:  BAVA) announces its 2010 full year results on Thursday, March 10. The company will host two conference calls on the same day at 9 a.m. (CET) and again at 4 p.m. (CET). A short presentation will be held by President and CEO, Anders Hedegaard, followed by a Q&A session. Also attending are Reiner Laus, EVP & Division President Cancer Vaccines, Ole Larsen, EVP & CFO and Rolf Sass Sørensen, VP Investor Relations & Communications. Dial-in numbers for the conference call are:  Denmark: +45 32 71 46 07, UK: +44 (0)20 7162 0077, US: +1 334 323 6201. For additional countries and further details please visit http://www.bavarian-nordic.com/ar2010 where also the accompanying presentation will be available in advance of the conference call. Contact Rolf Sass Sørensen, Vice President Investor Relations & Communications. E-mail: investor@bavarian-nordic.com Phone: +45 33 26 83 83 About Bavarian Nordic Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's clinical pipeline targets cancer and infectious diseases, and includes seven development programmes. Two programmes under preparation for Phase 3: PROSTVAC®, a therapeutic vaccine for advanced prostate cancer is being developed under a collaboration agreement with the National Cancer Institute, and IMVAMUNE®, a third-generation smallpox vaccine is being developed under a contract with the US government. Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA. For more information please visit www.bavarian-nordic.com This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Bavarian Nordic A/S via Thomson Reuters ONE [HUG#1495444]